← Back to Search

Retinoid

Vitamin A for CYP2D6 Polymorphism

Phase 1
Waitlist Available
Led By Mary F Hebert, PharmD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial looks at how a certain drug affects pregnant women.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
CYP2D6 activity: dextromethorphan metabolic ratio

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Vitamin AExperimental Treatment1 Intervention
Subjects will receive 3-4weeks of vitamin A
Group II: ControlActive Control1 Intervention
Subjects will receive no treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vitamin A
FDA approved

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,740 Previous Clinical Trials
1,847,856 Total Patients Enrolled
1 Trials studying CYP2D6 Polymorphism
36 Patients Enrolled for CYP2D6 Polymorphism
National Institute of General Medical Sciences (NIGMS)NIH
269 Previous Clinical Trials
248,728 Total Patients Enrolled
1 Trials studying CYP2D6 Polymorphism
36 Patients Enrolled for CYP2D6 Polymorphism
Mary F Hebert, PharmDPrincipal InvestigatorUniversity of Washington
1 Previous Clinical Trials
36 Total Patients Enrolled
1 Trials studying CYP2D6 Polymorphism
36 Patients Enrolled for CYP2D6 Polymorphism

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~11 spots leftby Apr 2025